(University of Michigan) With a shortage of new tuberculosis drugs in the pipeline, a software tool from the University of Michigan can predict how current drugs–including unlikely candidates — can be combined in new ways to create more effective treatments.
Original source: https://www.eurekalert.org/pub_releases/2019-11/uom-haa112119.php